Cargando…
COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641750/ https://www.ncbi.nlm.nih.gov/pubmed/34854413 http://dx.doi.org/10.4103/ijp.ijp_406_21 |
| _version_ | 1784609552518348800 |
|---|---|
| author | Bhardwaj, Ankit Roy, Vandana |
| author_facet | Bhardwaj, Ankit Roy, Vandana |
| author_sort | Bhardwaj, Ankit |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8641750 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86417502021-12-14 COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy Bhardwaj, Ankit Roy, Vandana Indian J Pharmacol Letter to the Editor Wolters Kluwer - Medknow 2021 2021-11-24 /pmc/articles/PMC8641750/ /pubmed/34854413 http://dx.doi.org/10.4103/ijp.ijp_406_21 Text en Copyright: © 2021 Indian Journal of Pharmacology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Letter to the Editor Bhardwaj, Ankit Roy, Vandana COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy |
| title | COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy |
| title_full | COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy |
| title_fullStr | COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy |
| title_full_unstemmed | COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy |
| title_short | COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy |
| title_sort | covid-19 associated mucormycosis, host-iron assimilation: probiotics can be a novel therapy |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641750/ https://www.ncbi.nlm.nih.gov/pubmed/34854413 http://dx.doi.org/10.4103/ijp.ijp_406_21 |
| work_keys_str_mv | AT bhardwajankit covid19associatedmucormycosishostironassimilationprobioticscanbeanoveltherapy AT royvandana covid19associatedmucormycosishostironassimilationprobioticscanbeanoveltherapy |